The Indian government has eased the ban on the export of the Hydroxychloroquine tablets to other countries.
Hydroxychloroquine And Its Uses
Hydroxychloroquine is an anti-malarial drug similar to chloroquine used in treating several forms of malaria as well as lupus erythematosus and rheumatoid arthritis.
It prevents malarial parasites from breaking down hemoglobin in RBC.
It is being studied around the globe as an experimental treatment for COVID-19 pandemic.
The drug is also considered as a first line treatment for various lung diseases.
India is the leading manufacturer of hydroxychloroquine tablets in the world and exports it to other countries.
Why in News?
Azithromycin and Hydroxychloroquine given in combination to positive COVID-19 patients has proved to be effective in eliminating the virus.
The Hydroxychloroquine and its similar drug chloroquine are under investigation for treatment of COVID-19 pandemic.
Doctors in korean nations have attained success in eliminating the pandemic by the use of antimalarial drugs.
Indian Council of Medical Research(IMCR) has advised doctors and healthcare workers for the use of hydroxychloroquine in treating the COVID-19 patients.
The United States of America has demanded these drugs from India and is pushing for the use of these drugs even though its effectiveness is not yet proven.